Search Results - "RUSSELL, Mason W"

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review by Gupta, Kiran, Miller, Jeffrey D, Li, Jim Z, Russell, Mason W, Charbonneau, Claudie

“…Summary Renal cell carcinoma (RCC), the most common form of kidney cancer, initially has an asymptomatic clinical course; 25–30% of patients present with…”
Get full text

Primary and subsequent coronary risk appraisal: New results from the Framingham study by D'Agostino, Ralph B, Russell, Mason W, Huse, Daniel M, Ellison, R.Curtis, Silbershatz, Halit, Wilson, Peter W.F, Hartz, Stuart C

“…Background Coronary heart disease continues to be one of the most common chronic illnesses in the United States and most of the developed world. Clinicians and…”
Get full text

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature by Foster, Talia S, Miller, Jeffrey D, Marton, Jeno P, Caloyeras, John P, Russell, Mason W, Menzin, Joseph

“…The costs of chronic obstructive pulmonary disease (COPD) pose a major economic burden to the United States. Studies evaluating COPD costs have generated…”
Get more information

A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients by Boulanger, Luke, Zhao, Yang, Bao, Yanjun, Russell, Mason W

“…Diabetic neuropathy (DN) is a common complication of diabetes that has significant economic burden, especially for patients with comorbid depression or…”
Get full text

Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain by Kwong, W. Jacqueline, PharmD, PhD, Özer-Stillman, Ipek, MS, Miller, Jeffrey D., MS, Haber, Noah A., BA, Russell, Mason W., MAPE, Kavanagh, Shane, MSc

“…Abstract Background: Tapentadol immediate-release (IR) tablets are indicated for the treatment of moderate to severe acute pain. In clinical trials, tapentadol…”
Get full text

Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis by Singh, Gurkirpal, Miller, Jeffrey D, Huse, Daniel M, Pettitt, Dan, D'Agostino, Ralph B, Russell, Mason W

“…OBJECTIVE: To estimate the potential effect on cardiovascular event occurrence and treatment costs associated with increases in systolic blood pressure (SBP)…”
Get full text

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis by Caloyeras, John P., MPhil, Zhang, Bin, MD, MSc, Wang, Cheng, MD, PhD, Eriksson, Marianne, MSc, Fredrikson, Sten, MD, PhD, Beckmann, Karola, MSc, Knappertz, Volker, MD, Pohl, Christoph, MD, Hartung, Hans-Peter, MD, Shah, Dhvani, MS, Miller, Jeffrey D., MS, Sandbrink, Rupert, MD, Lanius, Vivian, PhD, Gondek, Kathleen, PhD, Russell, Mason W., MAPE

“…Abstract Objectives To assess, from a Swedish societal perspective, the cost effectiveness of interferon β-1b (IFNB-1b) after an initial clinical event…”
Get full text

The economic burden of metastatic breast cancer: A systematic review of literature from developed countries by Foster, Talia S, Miller, Jeffrey D, Boye, Mark E, Blieden, Marissa B, Gidwani, Risha, Russell, Mason W

“…Abstract Objective Breast cancer, the most common malignant cancer among women in Western countries, has poor prognosis following metastasis. New therapies…”
Get full text

Current challenges in health economic modeling of cancer therapies: a research inquiry by Miller, Jeffrey D, Foley, Kathleen A, Russell, Mason W

“…The demand for economic models that evaluate cancer treatments is increasing, as healthcare decision makers struggle for ways to manage their budgets while…”
Get full text

Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey by Singh, Gurkirpal, Miller, Jeffrey D, Lee, Fleur H, Pettitt, Dan, Russell, Mason W

“…To estimate the prevalence of traditional risk factors for cardiovascular disease (CVD) among US adults with osteoarthritis (OA). Using survey data from the…”
Get full text

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain by Boulanger, Luke, Zhao, Yang, Foster, Talia S., Fraser, Kimberly, Bledsoe, Stacey L., Russell, Mason W.

“…ABSTRACT Objective: The objective of this retrospective analysis was to assess the correlation of comorbid depression and/or anxiety to patterns of treatment,…”
Get full text

Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data Bank by Boulanger, Luke, Joshi, Ashish V, Tortella, Bartholomew J, Menzin, Joseph, Caloyeras, John P, Russell, Mason W

“…Trauma is a serious injury or shock to the body from violence or crash and is an important and growing global health risk. Using 2000 to 2004 data from a…”
Get more information

Economic Burden of Follicular Non-Hodgkin’s Lymphoma by Foster, Talia, Miller, Jeffrey D., Boye, Mark E., Russell, Mason W.

“…Follicular non-Hodgkin’s lymphoma (FNHL), a slow-growing cancer of the immune system, constitutes about 15–30% of all incident non-Hodgkin’s lymphoma in…”
Get full text

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden by Gadler, Fredrik, Ding, Yao, Verin, Nathalie, Bergius, Martin, Miller, Jeffrey D, Lenhart, Gregory M, Russell, Mason W

“…The objective of this study was to quantify the impact that longer battery life of cardiac resynchronization therapy defibrillator (CRT-D) devices has on…”
Get full text

M1024 Does the Dosing Frequency of Proton Pump Inhibitors (PPIs) Affect Medication Adherence Among Patients Diagnosed with Gastroesophageal Reflux Disease (GERD)? by Boulanger, Luke, Mody, Reema, Bao, Yanjun, Kothari, Smita, Russell, Mason W

Get full text

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data by Miller, Jeffrey D, Foster, Talia, Boulanger, Luke, Chace, Meredith, Russell, Mason W, Marton, Jeno P, Menzin, Joseph

“…Chronic obstructive pulmonary disease (COPD) is a costly cause of morbidity and mortality in the U.S. The objective of this study was to use contemporary…”
Get more information

Direct Medical Costs of Coronary Artery Disease in the United States by Russell, Mason W, Huse, Daniel M, Drowns, Shelley, Hamel, Elizabeth C, Hartz, Stuart C

“…To generate current incidence-based estimates of the direct medical costs of coronary artery disease (CAD) in the United States, a Markov model of the economic…”
Get full text

Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children by Joshi, Ashish V., Munro, Vicki, Russell, Mason W.

“…ABSTRACT Objective: The objective of this study was to generate estimates of cost-effectiveness/utility of somatropin (rDNA origin) in the treatment of growth…”
Get full text

Cost-effectiveness of statins by Huse, Daniel M., Russell, Mason W., Miller, Jeffrey D., Kraemer, Dale F., D’Agostino, Ralph B., Ellison, R.Curtis, Hartz, Stuart C.

“…Currently, 6 hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are marketed in the United States (US). Given the wide variation in the…”
Get full text

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation by Huse, Daniel M, Cummins, Gordon, Taylor, Douglas C A, Russell, Mason W

“…The development of low-molecular-weight heparins (LMWHs) has made it possible to shift treatment of deep vein thrombosis (DVT) from inpatient to outpatient…”
Get full text